JavaScript seems to be disabled in your browser. You must have JavaScript enabled in your browser to utilize the functionality of this website.
Description: WEHI-539 is a potent and selective inhibitor of BCL-XL with IC50 value of 1.1 nM. WEHI-539 augments carboplatin induced caspase 3/7 activity, PARP cleavage and annexin V labelling. As a single agent, WEHI-539 causes noticeable PARP cleavage in Ovcar-4 (5 uM in Ovcar-4) and Ovsaho (1 uM in Ovsaho) cells. WEHI-539 not only binds very tightly to BCL-XL, with IC50 and KD values close to or below 1 nM and a slow dissociation rate, but also invokes apoptotic responses that are dependent on BAX, BAK or both. Furthermore, its biological activity is related to its binding profile, as elevated amounts of MCL-1, BCL-2 and BCL-W confer marked resistance, and its ability to destroy platelets is a well-validated marker of on-target BCL-XL inhibition.
References: J Ovarian Res. 2016 Apr 14; Nat Chem Biol. 2013 Jun; 9(6):390-7.
Related CAS#:2070018-33-4 (HCl salt)
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.
Request Data Sheet
Request product datasheet
Request safety datasheet
Compare
Add to wishlist
Get an offer
Request delivery time
Ask a technical question
Submit a bulk request
sales@hoelzel.de
« Back
Subscribe, get 15% off every fifth order and have your items delivered on time!
Forgot Your Password?
Not yet registered? Create account here!